Sandia Investment Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-30,000
Closed -$305K 309
2022
Q3
$305K Hold
30,000
0.05% 157
2022
Q2
$296K Hold
30,000
0.04% 187
2022
Q1
$300K Buy
+30,000
New +$297K 0.04% 190

Sandia Investment Management's FLACU Position: Q4 2022 in Review

Sandia Investment Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 30,000 shares — an estimated $305K sold.

Sandia Investment Management first reported a position in FLACU in Q1 2022 and held it in 3 quarters. The position peaked at $305K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

  • Sandia Investment Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
  • Sandia Investment Management sold 30,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $305K.
  • Sandia Investment Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q1 2022 and held it in 3 quarters.
  • Sandia Investment Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $305K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Sandia Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.